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Effector kinase Chk1 is an evolutionarily conserved protein kinase. It is a key mediator linking the mechanisms that monitor DNA 
integrity to components of the cell cycle engine. In this study, recombinant vectors pEGFP-C1-Chk1/C288/C334/C368 were 
constructed and transfected into HeLa cells to study the effect of the Chk1 regulatory domain on the regulation of subcellular 
Chk1 location in response to DNA damage. We found that DNA damage-induced nuclear accumulation is regulated by 34 amino 
acids (334–368) in the C-terminal regulatory domain. Recombinant vectors pXJ41-Chk1/C288/C334/C368 were co-transfected 
with reporter plasmid pEGFP-N2 into HeLa cells to study the repair abilities of the different human Chk1 truncation mutants. In 
addition, recombinant vectors were transfected into HeLa cells to study the effects of the different truncation mutants on the cell 
cycle. Furthermore, to study the kinase activity of the different truncation mutants, Ser216 phosphorylation of Cdc25C was stud-
ied by Western blot analysis. We found that the enzymatic activity of C368, missing the 108 C-terminal amino acids (368–476), 
was higher than that of full-length Chk1, and C368 delayed the cell cycle progression. The enzymatic activity of C334, missing 
the 142 C-terminal amino acids (334–476), was equivalent to that of full-length Chk1. C288, missing the 188 C-terminal amino 
acids (288–476), had almost no enzymatic activity, suggesting that the regulatory domain contains both inhibitory and regulatory 
elements. This study provides useful information for further research on Chk1 function. 
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Living organisms face tremendous challenges in accurately 
transmitting genetic material to subsequent generations. To 
maintain genomic integrity, cells have evolved mechanisms 
known as checkpoints that detect genomic perturbations and 
initiate a complex network of signal transduction pathways 
consisting of sensors, transducers, and effectors to mitigate 
deleterious effects [1]. The sensors detect DNA damage and 
aberrant DNA structures and initiate the signal response 
pathway. The transducers amplify the signal and relay it to 
effectors, which carry out a variety of activities, such as 
stopping cell cycle transitions, repairing damaged DNA and 
inducing cell death. 
Checkpoints allow the cell cycle to be arrested and ena-
ble the induction of genes that facilitate DNA repair. These 
checkpoints ensure that damaged DNA is not replicated in 
the S phase or passed on to daughter cells in mitosis. These 
responses ensure that DNA replication and chromosome 
segregation are completed with high accuracy. Checkpoint 
defects result in genomic instability, cell death, and a pre-
disposition to cancer. 
Checkpoint kinase 1 (Chk1) was first identified in fission 
yeast. Chk1 homologs have since been identified in mam-
mals, flies, budding yeast, worms, frogs and chickens. 
Checkpoint functions are largely conserved in these organisms 
[2]. Chk1 is an evolutionarily conserved protein kinase, 
which plays an important role in DNA damage-induced 
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checkpoint function [3,4]. Chk1 acts downstream of Atm- 
like proteins in yeasts and higher eukaryotes and regulates 
the checkpoint response that prevents chromosome segrega-
tion in the presence of DNA damage. Chk1 is a key media-
tor linking the mechanisms that monitor DNA integrity to 
components of the cell cycle engine [5]. Chk1 participates 
in the regulation of the cell cycle process, monitoring the 
integrity of genomic DNA and driving the repair of dam-
aged genomic DNA. Over-expression of Chk1 contributes 
to the self-repair of cells. However, under-expression or 
knockdown of Chk1 impairs the ability of cells to arrest the 
cell cycle at the G2/M phase and to trigger apoptosis [6–8]. 
The cell cycle checkpoint consists of ataxia telangiectasia 
mutated (ATM) and ATM Rad3 Related (ATR) protein ki-
nases, Chk1/2 and Cdc25A/B/C [9]. ATR and ATM phos-     
phorylate and activate Chk1, which is the key event in the 
Chk1 response to DNA damage and the arrest of DNA rep-    
lication. Activated Chk1 triggers the transduction and aug-     
mentation of the signal, leading to expression of target pro-     
teins and arrest of the cell cycle [10]. Inactivation of the 
Chk1 gene blocks the signaling pathway of the cell cycle 
checkpoint, as Chk1 is the target of ATM and ATR, which 
both control the signaling pathways that arrest the cell cycle 
after DNA damage [11]. 
One of the key events in the initiation of mitosis is the 
activation of CyclinB-Cdk1 [12]. Wee1 and Myt1 phos-
phorylate and inactivate CyclinB-Cdk1, while Cdc25C, a 
phosphatase, activates CyclinB-Cdk1 [13]. Chk1 has a piv-
otal role in the processes triggered by the checkpoint at the 
G2/M phase. When DNA damage occurs, Chk1 phosphory-
lates and inactivates Cdc25C, preventing the transition from 
G2 to M phase to allow for DNA repair [14]. Thus, the in-
hibitory phosphorylation of Cdc25C blocks mitosis and 
promotes the repair of damaged DNA. If DNA repair is 
completed, the cell cycle process continues [15]. 
Chk1 contains two structural domains: a kinase domain 
in the N-terminal half and a regulatory domain in the C- 
terminal half of the protein. An SQ/TQ domain (317–383) is 
located in the regulatory domain. Both ATR and ATM ki-
nases phosphorylate serine and threonine residues that are 
followed by glutamine (SQ/TQ). ATM phosphorylates Ser317 
and Ser345 of Chk1 in response to DNA damage. There is a 
nuclear location sequence (NLS) in motif 260–271 of Chk1 
(Figure 1) [16–21]. In yeast and mammalian cells Chk1 is 
located both in the cytoplasm and nuclei before DNA dam-
age, but it accumulates in nuclei after DNA damage, indi-
cating a distinct change in subcellular location [22]. Re-
combinant Chk1, expressed in cultured cells, displayed only 
basal enzymatic activity [5]. Unlike the full-length protein, 
C-terminus-truncated Chk1 leads to autophosphorylation 
and phosphorylation of Cdc25C at Ser216. The subcellular 
location of Chk1 and its ability to repair DNA damage, 
however, requires further exploration. 
In this study, a series of regulatory domain-truncated 
Chk1 mutations fused with green fluorescent protein (GFP)  
 
Figure 1  Structure of the Chk1 protein. A kinase domain is located in the 
N-terminal half and a regulatory domain is located in the C-terminal half of 
the protein. The SQ/TQ domain has several conserved Ser-Gln (SQ) or 
Thr-Gln (TQ) motifs, in which the serine or threonine residues are pre-
ferred phosphorylation sites of ATR or ATM. P represents phosphorylation 
sites. An SQ/TQ domain (317–383) is located in the regulatory domain. 
Both ATR and ATM kinases phosphorylate serine and threonine residues 
that are followed by glutamine (SQ/TQ). ATM phosphorylates Chk1 
Ser317 and Ser345 in response to DNA damage. There is a nuclear loca-
tion sequence (NLS) in motif 260–271. 
was used to investigate the subcellular location of Chk1. 
Chk1 and its truncation mutants were constructed into a 
pXJ41 vector. Cells were co-transfected with the Chk1 mu-
tant vectors and pEGFP-N2 to investigate the ability of the 
mutants to repair DNA damage. In addition, for analysis of 
the kinase activity of the different Chk1 truncation mutants, 
Ser216 phosphorylation of the Cdc25C protein, which is a 
downstream target of Chk1, was studied by Western blot 
analysis.  
1  Materials and methods 
1.1  Materials  
HeLa cells, pXJ41-neo, and eukaryotic expression vector, 
pEGFP-C1, were maintained in our lab. The transfection 
reagent VigoFect was purchased from Vigorous (Vigorous, 
Beijing). Restriction enzymes were purchased from Promega 
(Promega, Madison, WI). Oligo(dT)5 and Trizol RNA were 
purchased from Invitrogen (Invitrogen, Carlsbad, California). 
DMEM was purchased from GIBCO (GIBCO BRL, Invi-
trogen, USA). Phospho-cdc25C (Ser216)(63F9) rabbit mAb 
and cdc25C (5H9) rabbit mAb were purchased from Cell 
signaling Technology (Cell signaling Technology, Danvers, 
MA) and anti-rabbit IRDye800-linked IgG was obtained 
from Rockland Immunochemicals (Rockland Immuno-
chemicals, Inc., Gilbertsville, PA). Nucleoid occlusion pro-
tein (NOC), hydroxyurea (HU) and propidium iodide (PI) 
were purchased from Sigma (Sigma, St. Louis, MO). 
1.2  Construction of recombinant vectors 
Full-length human Chk1 cDNA was obtained by RT-PCR 
and cloned into pMD18-T. The target sequences of truncation 
mutations were amplified by PCR from pMD18-T-Chk1 and 
ligated into the pXJ41/pEGFP-C1 vector after both had been 
digested with EcoR I/Xho I (Promega). All PCR primers 
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were synthesized by Saibaisheng, China. All inserts in re-
combinant constructs were verified by DNA sequencing. 
1.3  Cell culture and transfection 
HeLa cells were cultured in DMEM supplemented with 
10% fetal bovine serum (GIBCO BRL) and maintained in a 
humid incubator at 37°C with 5% CO2. Recombinant ex-
pression vectors were transfected into HeLa cells grown on 
cover slips placed in 6-well plates with VigoFect (Vigorous) 
according to the manufacturer’s instructions. The medium 
was replaced after 12 h. 
1.4  Nuclear accumulation assay of the different Chk1 
mutants after DNA damage 
Forty hours after transfection with pEGFP-C1-Chk1, HeLa 
cells were damaged by UV irradiation (90 J/m2) for 0, 5, 10 or 
15 min and observed under a microscope (Olympus Fluoview 
300) to choose the optimal time to study the changes in 
subcellular location of Chk1 in response to DNA damage. 
pEGFP-C1-Chk1, pEGFP-C1-C288, pEGFP-C1-C334 
and pEGFP-C1-C368 were transfected into HeLa cells. 
Forty hours later, cells were UV-irradiated (90 J/m2) for 0, 5, 
10 or 15 min, respectively. The medium was discarded, and 
cells were fixed with methyl aldehyde for 10 min at 20°C. 
Cells were washed 3 times with PBS and once with distilled 
water. Distribution of GFP-Chk1 and the GFP-Chk1 mu-
tants was studied using microscopy (Olympus Fluoview 
300). To evaluate and quantify the nuclear location of 
GFP-Chk1 and the GFP-Chk1 mutants, positive cells were 
classified as follows: (1) N=C cells, the fluorescence inten-
sity is approximately equal in the nucleus and cytoplasm; (2) 
N>C cells, the fluorescence intensity in the nucleus is 
stronger than that in the cytoplasm. The number of cells 
belonging to each category and the number of cells emitting 
fluorescence were determined in different microscope fields. 
The relative ratios of cells belonging to the two categories 
were compared before and after DNA damage to analyze 
the changes in Chk1 location. Values were obtained by av-
eraging the results from at least 4 fields. 
1.5  Analysis of the abilities of the different truncation 
mutants to repair DNA damage 
The pEGFP-N2 plasmid was damaged by UV irradiation 
(90 J/m2) for 0, 10, 20, 30, 40 or 50 min and then transfect-
ed into HeLa cells. GFP expression of transfected cells was 
then studied under a microscope (Olympus Fluoview 300) 
to choose the optimal time to study the abilities of the dif-
ferent truncation mutants to repair DNA damage. 
HeLa cells were co-transfected with the truncation mu-
tants and pEGFP-N2 plasmids treated with UV, and were 
then studied under a fluorescence microscope (Olympus 
Fluoview 300). Cells emitting fluorescence were catego-
rized as positive cells. The fluorescence intensity and total 
cell number were analyzed in different microscope fields for 
cells transfected with each of the different truncation mu-
tants. At least 4 microscope fields were counted for each 
cell type. The fluorescence intensity, representing overall 
GFP expression, was calculated by Image Pro Plus (Media 
Cybernetics Inc.). 
1.6  Analysis of the effects of the different C-terminal 
truncation mutants on the cell cycle 
The cell cycle was halted at the G2/M phase, 24 h after 
transfection with the truncation mutants, by treatment with 
0.1 g/mL NOC (Sigma) for 16 h, after which the cells 
were harvested. For RT-PCR identification of transfection 
efficiency, total RNA was used as a template for amplifica-
tion of the neo gene. Cells were also fixed overnight in 70% 
ethanol, then washed twice with PBS, and finally incubated 
with 50 g/mL RNase at 37°C for 30 min. After incubation 
on ice for 1 min, PI (Sigma) was added and the cells were 
incubated at 4°C in the dark. This was followed by flow 
cytometry analysis (Becton Dickinson, San Jose, CA).  
1.7  Analysis of the kinase activity of the different 
C-terminal truncation mutants 
Cells were treated with 5 mmol/L HU (Sigma) for 18 and 48 
h after transfection with the different C-terminal truncation 
mutants and then harvested. Protein concentration was de-
termined by the BCA protein assay. To investigate the ki-
nase activity of the different C-terminal truncation mutants, 
Ser216 phosphorylation of the Cdc25C protein was ana-
lyzed by Western blot. Proteins were probed with a Phos-
pho-cdc25C(Ser216)(63F9) rabbit mAb (Cell signaling) or a 
cdc25C (5H9) rabbit mAb (Cell signaling), followed by 
incubation with an anti-rabbit IRDye800-linked IgG (Rock-
land Immunochemicals). Imaging films were scanned using 
the Odyssey infrared imaging system and read in gray val-
ues. Cdc25C was used as an internal reference to adjust the 
gray values of the target protein. The ratio of Ser216 phos-
phorylation of the Cdc25C protein in the cells without 
treatment by HU was set as 1. Data from 3 repeated exper-
iments with stable results were used for statistical analysis. 
For all experiments, statistical analyses were performed 
using Prism 4.0 software and P<0.05 was considered statis-
tically significant. 
2  Results 
2.1  Vector construction of Chk1 and Chk1 truncation 
mutants 
Full-length human Chk1 was cloned from the cDNA of 
HeLa cells. To investigate the functions of different Chk1 
domains, several truncation mutations were inserted into 
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pXJ41 and pEGFP-C1, including C288, missing the 188 
C-terminal amino acids (288–476), C334, missing the 142 
C-terminal amino acids (334–476) and C368, missing the 
108 C-terminal amino acids (368–476) (Figure 2). All of the 
plasmids were confirmed by sequencing. 
2.2  Nuclear accumulation of the different Chk1  
truncation mutants in response to DNA damage 
HeLa cells were transfected with pEGFP-C1-Chk1 and 40 h 
later cells were treated with UV irradiation for different 
durations. The subcellular localization of GFP-Chk1 was 
analyzed under a fluorescence microscope. Nuclear accu-
mulation of GFP-Chk1 increased with increasing duration 
of UV treatment (Figure 3). The percentage of cells with 
nuclear accumulation of GFP-Chk1 increased to a maxi-
mum after UV treatment for 10 min (Figure 4). However, 
the percentage of cells with nuclear accumulation of 
GFP-Chk1 declined (Figure 4) and the number of cells 
emitting fluorescence (Figure 3) was reduced after UV 
treatment for 15 min. Cells were seriously damaged after 
UV treatment for 15 min. We, therefore, chose 10 min as 
the optimal time to study the subcellular localization of 
Chk1 in response to DNA damage. 
Figures 5 and 6 show that the percentage of cells with 
nuclear accumulation of GFP-C368 and GFP-Chk1 increased 
in response to DNA damage caused by UV treatment for  
 
Figure 2  Structure of Chk1 and Chk1 truncation mutants. 
 
Figure 3  Nuclear accumulation of full-length Chk1 after UV treatment  
(90 J/m2) for 0, 5, 10 and 15 min, 24 h after transfection with pEGFP- 
C1-Chk1. (a) Expression of GFP-Chk1. (b) Propidium iodide (PI) staining. 
 
Figure 4  Relative ratios of cells with different subcellular locations of 
GFP-Chk1. (a) Cell categories. N=C cells, the GFP-Chk1 fluorescence 
intensity is approximately equal in the nucleus and cytoplasm; N>C cells, 
the GFP-Chk1 fluorescence intensity in the nucleus is stronger than that in 
the cytoplasm. (b) The relative ratio of cells with different subcellular 
locations of GFP-Chk1 0, 5, 10 and 15 min after UV treatment. 
10 min. The percentage of cells with nuclear accumulation 
of GFP-C368 is similar to the percentage of cells with 
nuclear accumulation of GFP-Chk1 after UV treatment. 
However, the percentages of cells with nuclear accumulation 
of GFP-C334 and GFP-C288 did not change after UV 
 
Figure 5  Nuclear accumulation of the different Chk1 truncation mutants 
after UV treatment. (a): Without UV treatment (–). (b): With UV treatment 
(+). 
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Figure 6  Nuclear accumulation of the different Chk1 truncation mutants 
after UV treatment. (a) Relative ratios of cells with different subcellular 
locations of the GFP-Chk1 mutants before (+) and after () UV treatment 
for 10 min. (b) Changes in localizations of the GFP-Chk1 mutants before 
and after UV treatment for 10 min expressed as the ratio between the (+) 
column and the () column in (a). Values are mean ± SD for at least 4 
microscope fields per cell type. **, compare with Chk1, P<0.01. 
treatment. This demonstrates that the sequence of 34 amino 
acids between GFP-C334 and GFP-C368 is very impor- 
tant for the regulation of nuclear accumulation of Chk1 in-
duced by DNA damage. 
2.3  Abilities of the different Chk1 truncation mutants 
to repair DNA damage 
pEGFP-N2 plasmids were treated with UV irradiation for 
different durations. HeLa cells were transfected with the 
treated pEGFP-N2 plasmids. Figures 7 and 8 show that 48 h 
after transfection the percentage of cells emitting fluores-
cence decreased with increasing duration of UV treatment. 
When UV treatment time exceeded 40 min, the pEGFP-N2 
plasmid was damaged too severely to express the GFP pro-
tein. We chose 40 min as the optimal treatment time to 
study the abilities of the different truncation mutants to re-
pair DNA damage. 
To study the abilities of the different Chk1 truncation muta-
tions to repair DNA damage, pEGFP-N2 plasmids were treated 
with UV for 40 min. Undamaged or damaged pEGFP-N2 
plasmids and different Chk1 truncation mutants were then 
co-transfected into HeLa cells. Undamaged pEGFP-N2 
co-transfected with pXJ41 into HeLa cells is control 1, 
damaged pEGFP-N2 co-transfected with pXJ41 into HeLa 
cells is control 2, and damaged pEGFP-N2 co-transfected 
with pXJ41-Chk1 into HeLa cells is control 3. Figures 9 and 
10 show that the fluorescence intensity of control 2 was 
markedly decreased compared with control 1. The fluores-
cence intensity of control 3 was stronger than the fluores-
cence intensity of control 2. The fluorescence intensity of 
cells co-transfected with damaged pEGFP-N2 and pXJ41- 
368 was stronger than that of control 3, the fluorescence 
intensity of cells co-transfected with damaged pEGFP-N2 
and pXJ41-334 was equivalent to that of control 3, and the 
fluorescence intensity of cells co-transfected with damaged 
pEGFP-N2 and pXJ41-228 was markedly weaker than that 
of control 3. These results indicate that the repair ability of 
C368 was higher than that of full-length Chk1, the repair 
ability of C334 was equivalent to that of full-length Chk1, 
and C288 had almost no repair ability. These data indicate 
that deletion of part of the Chk1 regulatory domain activated  
 
Figure 7  Fluorescence intensity of GFP after UV treatment of pEGFP-N2 for different durations. (a): GFP expression. (b): Overlay of bright field and 
green fluorescence images. 
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Figure 8  Fluorescence intensity of GFP after UV irradiation of pEGFP-N2 
for different durations.  
the kinase. When the entire SQ/TQ domain was deleted 
from the regulatory domain, Chk1 had no enzymatic activity. 
2.4  Effects of over-expression of the different Chk1 
truncation mutants on the cell cycle 
To study the effects of the different Chk1 mutants on the  
cell cycle, cells transfected with Chk1 or the Chk1 trunca-
tion mutants were treated with NOC, and cell cycles were 
analyzed by flow cytometry 16 h after transfection. RT- 
PCR for the neo gene indicated that transfection efficiencies 
of the different plasmids were approximately equal (Figure 
11). Untransfected cells are referred to as control 1, cells 
transfected with pXJ41 are referred to as control 2 and cells 
treated with NOC after transfection with pXJ41 are referred 
to as control 3. Figure 12 shows that there were no clear 
differences between the cell cycle progression of control 2 
and control 1. Cells of control 3 were trapped in the G2/M 
phase. Compared with control 3, cells treated with NOC after 
transfection with pXJ41-Chk1, pXJ41-C288 or pXJ41- 
C334 were trapped in the G2/M phase. Cells treated with 
NOC after transfection with pXJ41-C368 were not trapped 
in G2/M but had a delayed G1/S phase. Over-expression of 
Chk1, C334 or C288 did not disrupt cell cycle progres-
sion, but expression of the active C368 delayed the G1 or 
S phase. These results demonstrate that the enzymatic activ-
ities of the different Chk1 truncation mutants correlated  
 
Figure 9  Abilities of the different Chk1 truncation mutants to repair DNA damage. (a) GFP expression. (b) Overlay of bright field and green fluorescence images. 
 
Figure 10  Abilities of the different Chk1 truncation mutants to repair DNA 
damage, expressed as the fluorescence intensity. Values are mean ± SD for at 
least 4 microscope fields per cell type. $$, compare with control 1, P<0.01; 
##, compare with control 2, P<0.01; *, compare with control 3, P<0.05. 
 
 
Figure 11  Identification of the neo gene in cells transfected with the 
different Chk1 truncation mutants. 1, normal; 2, pXJ41; 3, pXJ41; 4, 
pXJ41-Chk1; 5, pXJ41-C288; 6, pXJ41-C334; 7, pXJ41-C368. 
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Figure 12  Effect of Chk1 and the different Chk1 mutations on the cell cycle with (+) and without (–) NOC treatment.  
with their effects on the cell cycle. Steric hindrance may 
exist in the regulatory domain of Chk1, and C368, which 
is missing the 108 C-terminal amino acids (368–476), may 
have an exposed latent active site because of disruption of 
this steric hindrance. This results in an enzymatic activity of 
C368 that is higher than that of full-length Chk1. These 
results demonstrate that the spatial structure of the C-terminal 
regulatory domain of Chk1 plays an important role in Chk1 
function. 
2.5  Kinase activity of the different Chk1 truncation 
mutants 
To study the kinase activity of the different Chk1 truncation 
mutants, cells transfected with Chk1 or different Chk1 
truncation mutants were treated with HU, and Ser216 
phosphorylation of the Cdc25C protein was analyzed by 
Western blot 18 h after HU treatment. HeLa cells transfect-
ed with pXJ41 are referred to as control 1, cells treated with 
HU after transfection with pXJ41 are referred to as control 2, 
and cells treated with HU after transfection with pXJ41- 
Chk1 are referred to as control 3. Figures 13 and 14 show 
that there was clearly greater Cdc25C Ser216 phosphoryla-
tion in control 2 compared with control 1. This may be re-
lated to the kinase activity of endogenous Chk1. Ser216 
phosphorylation of Cdc25C was stronger in control 3 than 
in control 2. This may be because of the combined kinase 
activity of endogenous and exogenous Chk1. Phosphoryla-
tion activity of C368 was stronger than that of full-length 
Chk1, phosphorylation activity of C334 was equivalent to 
that of full-length Chk1, and phosphorylation activity of 
C288 was equivalent to control 2. These results show that 
the kinase activity of C368 was higher than that of 
full-length Chk1, the kinase activity of C334 was equiva-
lent to that of full-length Chk1, and that C288 almost had 
 
Figure 13  Analysis of the kinase activity of the different Chk1 truncation 
mutants.  
 
Figure 14  Relative kinase activities of the different C-terminal truncation 
mutants. Cdc25C was used as an internal reference to adjust the gray val-
ues of the target protein. The ratio of Cdc25C Ser216 phosphorylation in 
cells without HU treatment was set as 1. Values are mean ± SD for 3 re-
peated experiments with stable results per cell type. HU = hydroxyurea. 
Compare with control 2, *, P<0.05; **, P<0.01; #, compare with control 3, 
P<0.05. 
no kinase activity. It further proves that deletion of part of 
the Chk1 regulatory domain activated the kinase. When the 
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entire SQ/TQ domain was deleted from the regulatory do-
main, Chk1 had no enzymatic activity. 
3  Discussion 
Chk1 accumulates in the nucleus of fission yeast cells that 
have been treated with the drug camptothecin, a DNA rep-
lication inhibitor. In a previous study, fusion proteins were 
generated by attaching enhanced yellow fluorescent protein 
(EYFP) in-frame to the amino terminus of full-length Chk1. 
After HeLa cells transfected with the EYFP vector were treated 
with the DNA-damaging agents, HU or methyl methane 
sulfonate (MMS) [22,23], accumulation of EYFP-Chk1 was 
observed in the nucleus of the cells [21]. These studies 
demonstrated a change in the subcellular localization of 
EYFP-Chk1 in response to HU and MMS-induced DNA 
damage. It is, therefore, necessary to study the nuclear ac-
cumulation sequence of Chk1 that regulates DNA dam-
age-induced Chk1 localization and function. Subcellular 
localization of a Chk1 deletion mutant missing the 115 
C-terminal amino acids (361–476) did not alter the check-
point-induced localization/retention of Chk1 [21]. These 
results suggest that the first 460 amino acids of Chk1 may 
be required for DNA damage-induced nuclear localization 
and retention of Chk1. An SQ/TQ domain (residues 317– 
383) contains putative phosphorylation sites for ATM/ATR 
and lies within the regulatory domain. Chk1 is phosphory-
lated on Ser317 and Ser345 in response to replication stress 
or other types of DNA damage in an ATM/ATR-dependent 
fashion [16–20]. To determine which part of the Chk1 pro-
tein is required for DNA damage-induced Chk1 nuclear 
localization and retention, we generated fusion proteins by 
attaching GFP in-frame at the C-terminus of Chk1 mutants 
missing different parts of the regulatory domain. HeLa cells 
were transfected with the different GFP fusion constructs 
and treated with UV irradiation to induce DNA damage, 
after which the nuclear localization of the different Chk1 
mutants was observed under a fluorescence microscope. 
Our results showed that the Chk1 deletion mutant C368, 
which lacks the 108 C-terminal amino acids (368–476), 
accumulated in the nucleus after UV treatment, while the 
subcellular localizations of the Chk1 deletion mutants 
C334, missing the 142 C-terminal amino acids (334–476), 
and C288, missing the 188 C-terminal amino acids (288– 
476), were not significantly different from wild-type Chk1. 
This suggests that a specific sequence of 34 amino acids 
(334–368) in the C-terminal regulatory domain is involved 
in regulating the DNA damage-induced nuclear retention of 
Chk1. In S. pombe, the interaction of Chk1 with 14-3-3 
proteins, which preferentially associate with active phos-
phorylated Chk1, is stimulated tenfold in response to DNA 
damage [24]. Human Chk1 also interacts with 14-3-3 pro-
tein, and the association between these proteins is stimulat-
ed by DNA damage [21]. It has recently been shown that 
14-3-3 proteins have a functional role in controlling the 
localization of certain binding partners [25]. In the case of 
Cdc25C, human Chk1 can phosphorylate the Ser216 residue 
of Cdc25 [26], creating a site for 14-3-3 protein binding 
[27]. Given the observations that Chk1 interacts with 14-3-3 
proteins and that 14-3-3 proteins are involved in the subcel-
lular localization of many of their binding partners, fur-
thermore, when cells incur DNA damage, Chk1 becomes 
phosphorylated and its interaction with 14-3-3 protein is 
stimulated approximately tenfold. We speculate that 14-3-3 
proteins regulate the subcellular localization of Chk1 by 
binding with Chk1, and the association of Chk1 with 14-3-3 
proteins plays a critical role in regulating Chk1 accumula-
tion in the nucleus in response to DNA damage. If the se-
quence that regulates the nuclear accumulation of Chk1 in 
response to DNA damage is deleted, the subcellular locali-
zation of Chk1 does not change after DNA damage. 
Ng et al. [5] incubated full-length Chk1 and a truncated 
mutant, C390, which lacked the 86 C-terminal amino acids 
(390–476), with radioactive ATP and found that full length 
Chk1 was only weakly radiolabeled, while C390 was robus-    
tly autophosphorylated. To measure the kinase activity of 
Chk1 against external substrates, a GST-Cdc25C195-259 fu-
sion protein containing the Chk1 phosphorylation site 
(Ser216) was used. Consistent with the autophosphorylation 
activity, Cdc25C was phosphorylated more strongly by 
C390 than by full-length Chk1. Further truncations of the 
C-terminus were made to characterize the regulatory regions. 
C309, missing the 167 C-terminal amino acids (309–476), 
still displayed some autophosphorylation activity, while 
C284, which lacks the 192 C-terminal amino acids 
(284–476) containing the entire SQ/TQ domain, displayed 
no autophosphorylation [5]. We, therefore, hypothesize that 
the C-terminal regulatory domain plays an important role in 
modulating the kinase domain. 
To investigate which part of the regulatory domain is in-
volved in regulating the kinase domain we first studied the 
abilities of the different Chk1 truncation mutants to repair 
DNA damage. Previous studies have used pEGFP-N2 as the 
reporter plasmid to investigate the ability of cells to repair 
DNA [28]. Therefore, we co-transfected HeLa cells with 
pEGFP-N2 and the Chk1 truncation mutants. We deter-
mined the fluorescence intensity as a measure of the repair 
capabilities of the different truncation mutants. The repair 
mediated by C368 was higher than that mediated by full- 
length Chk1, the repair mediated by C334 was equivalent 
to that mediated by full-length Chk1, while C288 had al-
most no ability to repair DNA. This suggests that the regu-
latory domain inhibits the enzymatic activity of Chk1, and 
deletion of part of the Chk1 regulatory domain activates the 
kinase. When the entire SQ/TQ domain was deleted from 
the regulatory domain, Chk1 had no enzymatic activity. 
We then studied the effects of the Chk1 truncation mu-
tants on the cell cycle to determine how the kinase domain 
of Chk1 is regulated by its regulatory domain. HeLa cells 
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were transfected with the different Chk1 truncation mutants. 
Flow cytometry analysis was performed after treatment with 
NOC. We found that whereas over-expression of Chk1, 
C334 and C288 did not perturb the cell cycle progression, 
expression of C368 severely compromised the NOC-induced 
G2/M block. These results demonstrate that expression of 
the active C368 delays the G1 or S phase. We found that 
the G1/S delay induced by the various truncation mutants of 
Chk1 correlated with their kinase activity. Among the stud-
ied truncation mutants, the enzymatic activity of C368 was 
the highest. 
Our results showed that C334, in which the 34 amino 
acids (334–368) involved in regulating the DNA dam-
age-induced nuclear accumulation of Chk1 were deleted, 
did not completely accumulate in the nucleus after DNA 
damage, while its repair competence was equivalent to full 
length Chk1. This suggests that nuclear accumulation of 
Chk1 is not the only pathway responding to DNA damage. 
Chk1 phosphorylates and inactivates Cdc25C by other sig-
naling pathways to prevent the cell cycle from progressing 
past the G2/M checkpoint to allow DNA repair. The enzy-
matic activity of C368 was higher than that of full-length 
Chk1, while the enzymatic activity of C334 was equiva-
lent to that of full-length Chk1. We speculate that the 142 
C-terminal amino acids (334–476) form a special spatial 
structure that blocks a latent active site lying within those 
142 amino acids from external contact. This may be the 
inhibitory element of the regulatory domain. Once the latent 
active site is exposed by destruction of the spatial structure, 
the enzymatic activity of C368 is higher than that of 
full-length Chk1. While C334 lacks the integral spatial 
structure formed by these 142 amino acids, it still has the 
regulatory elements of the regulatory domain and, thus, its 
enzymatic activity is equivalent to that of full-length Chk1. 
C288 lacks all regulatory elements of the regulatory do-
main, and it has almost no enzymatic activity. To verify this 
hypothesis, phosphorylation of Cdc25C was studied by 
Western blot to analyze the kinase activities of the different 
Chk1 truncation mutants. We found that the kinase activity 
of C368 was higher than that of full-length Chk1, the ki-
nase activity of C334 was equivalent to that of full-length 
Chk1, and C288 had almost no kinase activity. These re-
sults suggest that differences in phosphorylation of Cdc25C 
of the different deletion mutants relate to their differences in 
kinase activity. 
The results show that the kinase domain has enzymatic 
activity, and the regulatory domain controls the kinase do-
main by molecular interaction. The spatial structure of the 
C-terminal regulatory domain of Chk1 plays an important 
role in Chk1 function. Thus, removing parts of the regula-
tory domain could undermine these interactions. Deleting 
parts of the regulatory domain of Chk1 increased the kinase 
activity, and removal of the entire SQ/TQ domain deleted 
the kinase activity almost completely. These results suggest 
that the regulatory domain contains both inhibitory and reg-
ulatory elements: the SQ/TQ domain stimulates the kinase 
domain, but this is counteracted by suppression from the 
C-terminal region. The C-terminal region may act directly 
on the kinase domain or it may inhibit the activating poten-
tial of the SQ/TQ domain. The regulatory domain affects 
the kinase domain simply through steric hindrance, blocking 
the access of the kinase to Mg2+-ATP or substrates. Stress- 
induced phosphorylation of the SQ/TQ domain may remove 
the constraints of the C-terminal region on the kinase do-
main. 
In conclusion, a specific 34 amino acid sequence in the 
C-terminal regulatory domain of Chk1 is involved in the 
regulation of nuclear accumulation of Chk1 in response to 
DNA damage. When parts of the regulatory domain were 
truncated, Chk1 kinase activity was enhanced. However, 
when the entire SQ/TQ domain was removed the kinase 
activity of Chk1 disappeared almost entirely. This suggests 
that the regulatory domain is involved in regulating the ki-
nase domain. The mechanism of how the regulatory domain 
is involved in the regulation of DNA damage-induced nu-
clear accumulation and the kinase domain of Chk1 still re-
quires further exploration. 
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